{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:29:04Z","timestamp":1764732544798},"reference-count":33,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.3892\/or.2013.2424","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T10:00:04Z","timestamp":1366797604000},"page":"139-148","source":"Crossref","is-referenced-by-count":7,"title":["Crizotinib may be used in Lewis lung carcinoma: A novel use for crizotinib"],"prefix":"10.3892","volume":"30","author":[{"given":"PU","family":"XIA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEN-FENG","family":"GOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUANG","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUA-CHUAN","family":"ZHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"key20180107223910_b1-or-30-01-0139","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"6","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107223910_b2-or-30-01-0139","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/1535-7163.MCT-07-0365","article-title":"Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma","volume":"6","author":"Christensen","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key20180107223910_b3-or-30-01-0139","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1158\/0008-5472.CAN-06-4443","article-title":"An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms","volume":"67","author":"Zou","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107223910_b4-or-30-01-0139","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1021\/bi900438w","article-title":"Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors","volume":"48","author":"Timofeevski","year":"2009","journal-title":"Biochemistry"},{"key":"key20180107223910_b5-or-30-01-0139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.101120","article-title":"Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors","volume":"13","author":"Li","year":"2011","journal-title":"Neoplasia"},{"key":"key20180107223910_b6-or-30-01-0139","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1097\/JTO.0b013e318200f9ff","article-title":"Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer","volume":"5","author":"Ou","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key20180107223910_b7-or-30-01-0139","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1200\/jco.2011.29.15_suppl.7514","article-title":"Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005","volume":"29","author":"Crin\u00f2","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20180107223910_b8-or-30-01-0139","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180107223910_b9-or-30-01-0139","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2008.08.003","article-title":"Cancer stem cell markers in common cancers - therapeutic implications","volume":"14","author":"Klonisch","year":"2008","journal-title":"Trends Mol Med"},{"key":"key20180107223910_b10-or-30-01-0139","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1634\/stemcells.2006-0136","article-title":"Successful therapy must eradicate cancer stem cells","volume":"24","author":"Dingli","year":"2006","journal-title":"Stem Cells"},{"key":"key20180107223910_b11-or-30-01-0139","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1073\/pnas.0307618100","article-title":"Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line","volume":"101","author":"Kondo","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107223910_b12-or-30-01-0139","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1158\/0008-5472.CAN-07-0999","article-title":"Side population cells isolated from mesenchymal neoplasms have tumor initiating potential","volume":"67","author":"Wu","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107223910_b13-or-30-01-0139","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107223910_b14-or-30-01-0139","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymeth.2007.12.001","article-title":"Apoptosis and necrosis: detection, discrimination and phagocytosis","volume":"44","author":"Krysko","year":"2008","journal-title":"Methods"},{"key":"key20180107223910_b15-or-30-01-0139","first-page":"4243","article-title":"Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells","volume":"47","author":"Alessandri","year":"1987","journal-title":"Cancer Res"},{"key":"key20180107223910_b16-or-30-01-0139","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2298\/VSP0607635I","article-title":"Immunohistochemical analysis of angiogenesis in invasive ductal breast carcinoma with correlations to clinicopathological factor","volume":"63","author":"Ivkovi\u0107-Kapicl","year":"2006","journal-title":"Vojnosanit Pregl"},{"key":"key20180107223910_b17-or-30-01-0139","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1101\/gad.1002002","article-title":"Smad3 allostery links TGF-\u03b2 receptor kinase activation to transcriptional control","volume":"16","author":"Qin","year":"2002","journal-title":"Genes Dev"},{"key":"key20180107223910_b18-or-30-01-0139","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainresbull.2007.01.010","article-title":"Gene expression profile in \u03b2-amyloid-treated SH-SY5Y neuroblastoma cells","volume":"72","author":"Mart\u00ednez","year":"2007","journal-title":"Brain Res Bull"},{"key":"key20180107223910_b19-or-30-01-0139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.09948","article-title":"An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis","volume":"12","author":"Zillhardt","year":"2010","journal-title":"Neoplasia"},{"key":"key20180107223910_b20-or-30-01-0139","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/or.2012.2198","article-title":"Effect of PF-02341066 and radiation on non-small cell lung cancer cells","volume":"29","author":"Tumati","year":"2012","journal-title":"Oncol Rep"},{"key":"key20180107223910_b21-or-30-01-0139","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","article-title":"A distinct \u2018side population\u2019 of cells with high drug efflux capacity in human tumor cells","volume":"101","author":"Hirschmann-Jax","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 3","key":"key20180107223910_b22-or-30-01-0139","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0305-7372(10)70016-5","article-title":"Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma","volume":"36","author":"Bronte","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"key20180107223910_b23-or-30-01-0139","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djq184","article-title":"ALK, lung cancer, and personalized therapy: portent of the future?","volume":"102","author":"Garber","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key20180107223910_b24-or-30-01-0139","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrclinonc.2010.64","article-title":"Targeted therapy in non-small-cell lung cancer - is it becoming a reality?","volume":"7","author":"Janku","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"key20180107223910_b25-or-30-01-0139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/stemcells.2005-0116","article-title":"A side order of stem cells: the SP phenotype","volume":"24","author":"Challen","year":"2006","journal-title":"Stem Cells"},{"key":"key20180107223910_b26-or-30-01-0139","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1016\/j.yexcr.2006.08.030","article-title":"SP analysis may be used to identify cancer stem cell populations","volume":"312","author":"Hadnagy","year":"2006","journal-title":"Exp Cell Res"},{"key":"key20180107223910_b27-or-30-01-0139","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK","volume":"27","author":"Shaw","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107223910_b28-or-30-01-0139","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.7314\/APJCP.2012.13.7.3119","article-title":"Predictive role of computer simulation in assessing signaling pathways of crizotinib-treated A549 lung cancer cells","volume":"13","author":"Xia","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107223910_b29-or-30-01-0139","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1158\/1078-0432.CCR-03-0512","article-title":"Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter","volume":"10","author":"Jacob","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107223910_b30-or-30-01-0139","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ymthe.2004.02.007","article-title":"Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms","volume":"9","author":"Zhu","year":"2004","journal-title":"Mol Ther"},{"key":"key20180107223910_b31-or-30-01-0139","first-page":"3929","article-title":"Induction of p21waf1 expression and growth inhibition by transforming growth factor \u03b2 involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells","volume":"57","author":"Grau","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107223910_b32-or-30-01-0139","first-page":"185","article-title":"Overexpression of transforming growth factor (TGF) \u03b21 type II receptor restores TGF-\u03b21 sensitivity and signaling in human prostate cancer cells","volume":"9","author":"Guo","year":"1998","journal-title":"Cell Growth Differ"},{"key":"key20180107223910_b33-or-30-01-0139","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-012-0727-0","article-title":"CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway","volume":"17","author":"Tang","year":"2012","journal-title":"Apoptosis"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2424\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:49:43Z","timestamp":1515365383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,4,24]]},"published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.3892\/or.2013.2424"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2424","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,24]]}}}